Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Kadmon Holdings, Inc. (KDMN)
Sector: Healthcare; Industry: Biotechnology

Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-03-13 Waksal Harlan President, CEO Buy 16,000 $2.93 $46,811 No
2020-03-12 Schwalm Cynthia Director Buy 31,000 $3.24 $100,393 No
2020-03-11 Waksal Harlan President, CEO Buy 12,600 $3.96 $49,859 No
2019-11-18 PERCEPTIVE ADVISORS LLC Former 10% owner Buy 1,470,588 $3.40 $4,999,999 No
2017-06-29 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 64,415 $4.04 $260,546 No
2017-09-06 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 302,950 $2.73 $827,530 No
2017-08-11 Wiviott Susan Director Buy 2,000 $2.22 $4,433 No
2017-08-10 Waksal Harlan President, CEO Buy 5,000 $2.27 $11,332 No
2017-08-08 Gordon Steven N. Exec VP, GC, Chief Admin, Comp Buy 1,000 $2.47 $2,471 No
2017-08-08 Waksal Harlan President, CEO Buy 3,707 $2.34 $8,667 No
2017-08-08 Bauer Eugene Director Buy 5,000 $2.36 $11,800 No
2017-07-31 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 349,661 $2.60 $909,119 No
2017-07-11 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 34,462 $3.69 $127,165 No
2017-06-29 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 64,375 $4.04 $260,384 No
2017-06-27 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 108,827 $3.69 $401,768 No
2017-06-26 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 515,643 $3.51 $1,812,066 No
2017-06-22 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 767,363 $3.50 $2,685,157 No
2017-06-22 GOLDENTREE ASSET MANAGEMENT LP 10%-Owner Sell 767,363 $3.50 $2,685,157 No
2017-03-13 Loeb Daniel S 10%-Owner Buy 1,488,095 $3.36 $4,999,999 Yes
2016-11-16 Waksal Harlan President, CEO Buy 2,000 $6.37 $12,733 No
2016-11-14 Waksal Harlan President, CEO Buy 2,000 $6.79 $13,580 No
2016-11-11 Poukalov Konstantin EVP, Chief Financial Officer Buy 4,000 $5.81 $23,250 No
2016-09-14 Loeb Daniel S 10%-Owner Buy 19,611 $7.79 $152,817 No
2016-09-13 Loeb Daniel S 10%-Owner Buy 68,654 $8.33 $572,029 No
2016-09-06 Loeb Daniel S 10%-Owner Buy 81,781 $9.39 $767,612 No
2016-08-26 Loeb Daniel S 10%-Owner Buy 32,916 $9.98 $328,482 No
2016-08-22 Loeb Daniel S 10%-Owner Buy 11,305 $10.00 $113,043 No
2016-08-15 Loeb Daniel S 10%-Owner Buy 6,010 $9.95 $59,824 No
2016-08-12 Loeb Daniel S 10%-Owner Buy 87,529 $9.98 $873,869 No
2016-08-05 Loeb Daniel S 10%-Owner Buy 66,828 $9.94 $664,455 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.